Ligand Pharmaceuticals Incorporated Common Stock (NASDAQ: LGND) last traded at $301.81, up 2.31% on the session. The quote above updates while this page is open; the figures below are drawn from Ligand Pharmaceuticals Incorporated Common Stock’s own filings and are restated only when a new one is published.
Ligand Pharmaceuticals Incorporated Common Stock trades on NASDAQ under the ticker LGND. Its market capitalisation is $6.02 billion.
Valuation measures for Ligand Pharmaceuticals Incorporated Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $6.02B |
|---|---|
| Enterprise value | $6.23B |
| P/E ratio | 31.28 |
| Price / sales | 20.71 |
| Price / book | 6.22 |
| Beta |
| 0.76 |
Trailing-twelve-month figures tagged in Ligand Pharmaceuticals Incorporated Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $290.54M |
|---|---|
| Net income (TTM) | $197.22M |
| EPS (TTM) | $9.65 |
| Operating margin | 32.61% |
| Return on equity | 20.38% |
| Cash | $1.01B |
Range and volume for LGND over the past 52 weeks.
| 52-week high | $326.63 |
|---|---|
| 52-week low | $175.89 |
| Volume | 183.0K |
| Average volume | 257.4K |
| Previous close | $295.00 |
Invest a chosen dollar amount in Ligand Pharmaceuticals Incorporated Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell LGND.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.